DeepTek.ai and AiOne form strategic partnership for medical imaging

  • 5 January 2024
DeepTek.ai and AiOne form strategic partnership for medical imaging
2140344443

A new partnership between healthcare tech provider AiOne Healthcare Technologies Ltd and AI tech company DeepTek.ai is set to enhance diagnostic accuracy within AI-powered medical imaging analysis and streamline workflow for healthcare providers.

AiOne will be providing DeepTek.ai with market access and support in the UK, as the US company aims to seamlessly integrate its solutions into existing healthcare workflows. The company develops solutions that are designed to improve radiologists’ accuracy and efficiency through the use of its AI-powered tools that help with the interpretation of medical images.

Augmento is DeepTek’s flagship product. The AI-powered orchestration platform automates routine tasks, streamlines workflow and delivers real-time insights to radiologists. As a result, diagnostic accuracy can be improved by as much as 20%, with a reduction in reporting time of up to 50%.

Another of DeepTek’s tools – the chest x-ray screening solution, Genki – received approval from the Thai Food and Drug Administration (FDA) in September last year.

Dr Amit Kharat, CEO and co-founder of DeepTek, said: “We are excited to partner with AiOne to bring our cutting-edge AI solutions to the UK market. The UK has a world-class healthcare system, and we believe that our AI solutions can help to improve patient care further.”

AiOne specialises in integrating AI and other innovative technologies into healthcare workflows, with a mission to improve patient care in the process.

Director and CEO of AiOne, Dr Santosh Pillai, said: “We are delighted to partner with DeepTek.ai and introduce their innovative AI solutions to the UK market. We believe that these solutions have the potential to revolutionise the way medical imaging is analysed and interpreted, leading to better patient care.”

Subscribe To Our Newsletters

Subscribe to our newsletter

Subscribe To Our Newsletter

Related News

Health sector cautiously welcomes NHS AI rollout

Health sector cautiously welcomes NHS AI rollout

Figures from across the health sector have cautiously welcomed the news that NHS England is accelerating the rollout of AI tools.
NHS AI blood test could reduce invasive cancer exams for women

NHS AI blood test could reduce invasive cancer exams for women

Thousands of women could avoid invasive diagnostic procedures for suspected womb cancer under an NHS trial of an AI blood test.
Griffiths: ‘People in digital have to work at the top of their game’

Griffiths: ‘People in digital have to work at the top of their game’

Andrew Griffiths, chief executive of FEDIP, explains why NHS England’s new “expectation” of registration is a turning point.